Several meta-analyses showed that the polymorphism 164A>C in CYP1A2 gene can result in 2–3 fold increase in the CYP1A2 activity, which has been associated with increased cancer risk, primarily lung cancer in Caucasians [24–27]. This evidence concerns the gene CYP1A2 and lung carcinoma.